Avidity biosciences highlights fshd program at virtual investor and analyst event

La jolla, calif., dec. 9, 2021 /prnewswire/ -- avidity biosciences, inc. (nasdaq: rna), a biopharmaceutical company committed to delivering a new class of rna therapeutics called antibody oligonucleotide conjugates (aocs™), today announced it will be hosting a live webcast investor and analyst day event titled "volume 3: delivering on aocs - fshd" at 11:00am et.

RNA Ratings Summary

RNA Quant Ranking